Evaluating the Efficacy and Safety of ZytuxTM (Rituximab, AryoGen Pharmed) in Iranian Multiple Sclerosis Patients: An observational Study
Conclusion: The observed results revealed that the ZytuxTM could have a positive and significant effect on all types of MS.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Clinical Trials | Disability | Iran Health | Middle East Health | MRI Scan | Multiple Sclerosis | Neurology | Pain | Pneumonia | Rituxan | Skin | Study | Urinary Tract Infections